Resiquimod Uses, Dosage, Side Effects and more
A substance being studied in the treatment of some types of skin cancer. When put on the skin, resiquimod causes some immune cells to make certain chemicals that may help them kill tumor cells. It is also being studied to find out if adding it to a tumor vaccine improves the antitumor immune response. It is a type of imidazoquinoline and a type of immunomodulator.
| Trade Name | Resiquimod |
| Generic | Resiquimod |
| Resiquimod Other Names | Resiquimod |
| Type | |
| Formula | C17H22N4O2 |
| Weight | Average: 314.3822 Monoisotopic: 314.174275968 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in genital herpes.
How Resiquimod works
Resiquimod is a Toll-like receptor 7 (TLR7) and TLR8 agonist that is a potent inducer of alpha interferon (IFN-alpha) and other cytokines.
